5-Pentadecylresorcinol
Based on 2 publication(s) in Google Scholar
5-Pentadecylresorcinol (Adipostatin A) is a glycerol-3-phosphate dehydrogenase (GPDH) inhibitor with an IC50 of 4.1 μM. Adipostatin A shows good larvicidal activity against Aedes aegypti.
For research use only. We do not sell to patients.
- Purity: 99.31%
- CAS No.: 3158-56-3
- Formula: C21H36O2
- Molecular Weight:320.51
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) 5-Pentadecylresorcinol
More
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
1.31 μM
Compound: 9
|
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
Cytotoxicity against human A2780 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| A549 | ED50 |
2.37 μg/mL
Compound: 6
|
Cytotoxicity against human A549 cells after 7 days
Cytotoxicity against human A549 cells after 7 days
|
[PMID: 8201311] |
| A549 | IC50 |
1.43 μM
Compound: 9
|
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
Cytotoxicity against human A549 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| Bel-7402 | IC50 |
1.93 μM
Compound: 9
|
Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
Cytotoxicity against human Bel-7402 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| BGC-823 | IC50 |
1.74 μM
Compound: 9
|
Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
Cytotoxicity against human BGC-823 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| BT-20 | IC50 |
6.25 μg/mL
Compound: Page3979, R5C1
|
Growth inhibition of human BT20 cells
Growth inhibition of human BT20 cells
|
[PMID: 21658963] |
| FM3A | IC50 |
2.8 μM
Compound: Page3979, R5C1
|
Growth inhibition of mouse FM3A cells
Growth inhibition of mouse FM3A cells
|
[PMID: 21658963] |
| HCT-8 | IC50 |
1.48 μM
Compound: 9
|
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
Cytotoxicity against human HCT8 cells after 96 hrs by MTT assay
|
[PMID: 17125236] |
| HeLa | IC50 |
4.02 μg/mL
Compound: Page3979, R5C1
|
Growth inhibition of human HeLa cells
Growth inhibition of human HeLa cells
|
[PMID: 21658963] |
| HT-29 | ED50 |
3.25 μg/mL
Compound: 6
|
Cytotoxicity against human HT-29 cells after 7 days
Cytotoxicity against human HT-29 cells after 7 days
|
[PMID: 8201311] |
| MCF7 | ED50 |
2.41 μg/mL
Compound: 6
|
Cytotoxicity against human MCF7 cells after 7 days
Cytotoxicity against human MCF7 cells after 7 days
|
[PMID: 8201311] |
| MCF7 | IC50 |
37 μM
Compound: 13
|
Cytotoxicity against human MCF7 cells
Cytotoxicity against human MCF7 cells
|
[PMID: 17243726] |
| MCF7 | IC50 |
37 μM
Compound: Page3979, R5C1
|
Growth inhibition of human MCF7 cells
Growth inhibition of human MCF7 cells
|
[PMID: 21658963] |
| NCI-H460 | IC50 |
34.2 μM
Compound: 13
|
Cytotoxicity against human NCI-H460 cells
Cytotoxicity against human NCI-H460 cells
|
[PMID: 17243726] |
| NCI-H460 | IC50 |
34.2 μM
Compound: Page3979, R5C1
|
Growth inhibition of human NCI-H460 cells
Growth inhibition of human NCI-H460 cells
|
[PMID: 21658963] |
| SF-268 | IC50 |
39.8 μM
Compound: 13
|
Cytotoxicity against human SF268 cells
Cytotoxicity against human SF268 cells
|
[PMID: 17243726] |
5-Pentadecylresorcinol (Adipostatin A) prevents triglyceride accumulation in 3T3-L1 cells at a concentration of the microM level[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3158-56-3
-
Appearance Solid
-
Molecular Weight 320.51
-
Formula C21H36O2
-
Color Off-white to light yellow
-
SMILES
OC1=CC(O)=CC(CCCCCCCCCCCCCCC)=C1
-
Synonyms
Adipostatin A
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Mol Cell
Serine synthesis sustains macrophage IL-1β production via NAD+-dependent protein acetylation. [Abstract]2024 Feb 15;84(4):744-759.e6. PMID: 38266638 -
Cell Death Differ
A neutrophil-intrinsic CKLF1-PKM2 axis drives glycolytic flux for de novo DAG synthesis and pro-inflammatory ROS production. [Abstract]2026 May 12. PMID: 42120940
Solvent & Solubility
DMSO : 100 mg/mL (312.00 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 1.25 mg/mL (3.90 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 1.25 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (267 KB)
-
SDS (392 KB)
- English - EN (392 KB)
- Français - FR (392 KB)
- Deutsch - DE (392 KB)
- Norwegian - NO (392 KB)
- Español - ES (392 KB)
- Swedish - SV (392 KB)
- Italian - IT (392 KB)
- Korean - KR (392 KB)
- Portuguese - PT (392 KB)
-
Handling Instructions (2659 KB)
References
[1]. Tsuge, et al. Adipostatins A and B, new inhibitors of glycerol-3-phosphate dehydrogenase. J Antibiot (Tokyo). 1992 Jun;45(6):886-91. [Content Brief]
[2]. Micheline Soares Costa Oliveira, et al. Antioxidant, larvicidal and antiacetylcholinesterase activities of cashew nut shell liquid constituents. Acta Trop. 2011 Mar;117(3):165-70. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.1200 mL | 15.6001 mL | 31.2003 mL | 78.0007 mL |
| 5 mM | 0.6240 mL | 3.1200 mL | 6.2401 mL | 15.6001 mL | |
| 10 mM | 0.3120 mL | 1.5600 mL | 3.1200 mL | 7.8001 mL | |
| 15 mM | 0.2080 mL | 1.0400 mL | 2.0800 mL | 5.2000 mL | |
| 20 mM | 0.1560 mL | 0.7800 mL | 1.5600 mL | 3.9000 mL | |
| 25 mM | 0.1248 mL | 0.6240 mL | 1.2480 mL | 3.1200 mL | |
| 30 mM | 0.1040 mL | 0.5200 mL | 1.0400 mL | 2.6000 mL | |
| 40 mM | 0.0780 mL | 0.3900 mL | 0.7800 mL | 1.9500 mL | |
| 50 mM | 0.0624 mL | 0.3120 mL | 0.6240 mL | 1.5600 mL | |
| 60 mM | 0.0520 mL | 0.2600 mL | 0.5200 mL | 1.3000 mL | |
| 80 mM | 0.0390 mL | 0.1950 mL | 0.3900 mL | 0.9750 mL | |
| 100 mM | 0.0312 mL | 0.1560 mL | 0.3120 mL | 0.7800 mL |